Cargando…
Synthesis of a novel (89)Zr-labeled HER2 affibody and its application study in tumor PET imaging
BACKGROUND: Human epidermal growth factor receptor-2 (HER2) is an essential biomarker for tumor treatment. Affibody is an ideal vector for preparing HER2 specific probes because of high affinity and rapid clearance from normal tissues, etc. Zirconium-89 is a PET imaging isotope with a long half-life...
Autores principales: | Xu, Yuping, Wang, Lizhen, Pan, Donghui, Yan, Junjie, Wang, Xinyu, Yang, Runlin, Li, Mingzhu, Liu, Yu, Yang, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271293/ https://www.ncbi.nlm.nih.gov/pubmed/32495181 http://dx.doi.org/10.1186/s13550-020-00649-7 |
Ejemplares similares
-
PET of HER2 Expression with a Novel (18)FAl Labeled Affibody
por: Xu, Yuping, et al.
Publicado: (2017) -
HER3 PET Imaging: (68)Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to (89)Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
por: Rinne, Sara S., et al.
Publicado: (2021) -
PET Imaging of FSHR Expression in Tumors with (68)Ga-Labeled FSH1 Peptide
por: Pan, Donghui, et al.
Publicado: (2017) -
PET imaging of epidermal growth factor receptor expression in tumours using (89)Zr-labelled ZEGFR:2377 affibody molecules
por: GAROUSI, JAVAD, et al.
Publicado: (2016) -
Targeting HER2-positive gastric cancer with a novel (18)F-labeled Z(HER2:342) probe
por: Pan, Yunyun, et al.
Publicado: (2019)